Intressanta studier med Besponsa (inotuzumab ozogamizin)
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia
Stock et al, Cancer, 2021 Mar 15;127(6):905-913
https://pubmed.ncbi.nlm.nih.gov/33231879/
Relaterade behandlingsområden
PP-INO-SWE-0036, mar 2022